Exicure XCUR
NASDAQ XCUR
$1.15 -0.15 (-11.54%)
As of: Aug 21, 2026 · 3:59 PM EDT

Exicure (XCUR) Cash & Equivalents (2016 - 2026)

Exicure's (XCUR) quarterly Cash & Equivalents came in at $2.6 million in Q1 2026, down 75.01% YoY from $10.4 million in Q1 2025, and down 30.49% on a QoQ basis from $3.7 million in Q4 2025.

Exicure (XCUR) Cash & Equivalents (2016 - 2026) Analysis & Trends

Exicure (XCUR) has 11 years of Cash & Equivalents data on file, last reported at $2.6 million in Q1 2026.

  • Quarterly Cash & Equivalents fell 75.01% year-over-year to $2.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 million (down 75.01% YoY) and the FY2025 annual result came in at $3.7 million, down 70.05% from the prior year.
  • Cash & Equivalents slipped to $2.6 million in Q1 2026, from $3.7 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $23.9 million in Q1 2022 to a low of $343000.0 in Q3 2024.
  • A 5-year average of $7.6 million and a median of $4.4 million in 2025 frame the typical range for Cash & Equivalents.
  • Annual changes were most pronounced in 2024 — Cash & Equivalents plunged 96.33% — and 2025, when it soared 2746.99%.
  • Tracing XCUR's Cash & Equivalents over 5 years: stood at $9.8 million in 2022, then sank by 79.38% to $2.0 million in 2023, then jumped by 520.44% to $12.5 million in 2024, then plunged by 70.05% to $3.7 million in 2025, then plunged by 30.49% to $2.6 million in 2026.
  • The last three Cash & Equivalents figures came in at $2.6 million (Q1 2026), $3.7 million (Q4 2025), and $4.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 6.14 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 2.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 3.58 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 1.72 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 5.10 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 1.71 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 8.93 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 544.80 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 811.99 Mn
10 Exicure 7.27 Mn 7.27 Mn - 1.72 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.60 Mn
Dec 31, 2025 3.75 Mn
Sep 30, 2025 4.44 Mn
Jun 30, 2025 7.86 Mn
Mar 31, 2025 10.42 Mn
Dec 31, 2024 12.51 Mn
Sep 30, 2024 343,000.00
Jun 30, 2024 528,000.00
Mar 31, 2024 366,000.00
Dec 31, 2023 2.02 Mn
Sep 30, 2023 922,000.00
Jun 30, 2023 2.34 Mn
Mar 31, 2023 9.96 Mn
Dec 31, 2022 9.78 Mn
Sep 30, 2022 15.65 Mn
Jun 30, 2022 21.20 Mn
Mar 31, 2022 23.89 Mn
Dec 31, 2021 34.64 Mn
Sep 30, 2021 51.89 Mn
Jun 30, 2021 42.59 Mn